Tumor protein D52 (TPD52) is a protein found to be overexpressed in prostate and breast cancer due to gene amplification. However, its physio-logical function remains under investigation. In the present study, we inves-tigated the response of the LNCaP human prostate carcinoma cell line to deregulation of TPD52 expression.